U S PHYSICAL THERAPY INC /NV Earnings Per Share (Basic)
U S PHYSICAL THERAPY INC /NV (USPH) reported Earnings Per Share (Basic) of $0.25 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV earnings per share, basic for the quarter ending 2026-06-30 was $0.25, a 56.90% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic for the quarter ending 2026-03-31 was -$0.12, a 115.00% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic for the quarter ending 2025-09-30 was $0.48, a 23.08% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic for the quarter ending 2025-06-30 was $0.58, a 23.40% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic for fiscal 2025 was $1.42, a 22.83% decline from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic for fiscal 2024 was $1.84, a 43.75% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic for fiscal 2023 was $1.28, a 43.11% decline from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic for fiscal 2022 was $2.25, a 6.64% decline from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.25 10-Q · filed 2026-08-07 | $0.13 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | -$0.12 10-Q · filed 2026-05-08 | ||||
| 2025-12-31 | $1.42 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $0.48 10-Q · filed 2025-11-07 | $1.85 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $0.58 10-Q · filed 2026-08-07 | $1.38 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | $0.80 10-Q · filed 2026-05-08 | ||||
| 2024-12-31 | $1.84 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $0.39 10-Q · filed 2025-11-07 | $1.32 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | $0.47 10-Q · filed 2025-08-08 | $0.93 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | $0.46 10-Q · filed 2025-05-09 | ||||
| 2023-12-31 | $1.28 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $0.51 10-Q · filed 2024-11-08 | $1.72 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | $0.64 10-Q · filed 2024-08-14 | $1.22 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $0.58 10-Q · filed 2024-05-08 | ||||
| 2022-12-31 | $2.25 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $0.72 10-Q · filed 2023-11-08 | $2.27 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | $0.87 10-Q · filed 2023-08-09 | $1.55 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | $0.67 10-Q · filed 2023-05-05 | ||||
| 2021-12-31 | $2.41 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $0.66 10-Q · filed 2022-11-08 | $1.69 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | $0.82 10-Q · filed 2022-08-08 | $1.03 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | $0.21 10-Q · filed 2022-05-09 | ||||
| 2020-12-31 | $2.48 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $0.61 10-Q · filed 2021-11-09 | $1.80 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $0.99 10-Q · filed 2021-08-09 | $1.19 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | $0.20 10-Q · filed 2021-05-10 | ||||
| 2019-12-31 | $2.45 10-K · filed 2022-03-01 | ||||
| 2016-12-31 | $0.09 derived: net income ÷ weighted average shares · filed 2018-03-14 | $0.72 derived: net income ÷ weighted average shares · filed 2018-03-14 | $1.50 derived: net income ÷ weighted average shares · filed 2018-03-14 | $2.10 derived: net income ÷ weighted average shares · filed 2018-03-14 | |
| 2016-09-30 | $0.46 10-Q · filed 2016-11-04 | $1.41 derived: net income ÷ weighted average shares · filed 2017-11-07 | $1.45 10-Q · filed 2016-11-04 | $2.31 derived: net income ÷ weighted average shares · filed 2018-03-14 | |
| 2016-06-30 | $0.57 10-Q · filed 2016-08-05 | $0.99 10-Q · filed 2016-08-05 | $1.68 derived: net income ÷ weighted average shares · filed 2018-03-14 | $2.31 derived: net income ÷ weighted average shares · filed 2018-03-14 | |
| 2016-03-31 | $0.43 10-Q · filed 2016-05-06 | $0.90 derived: net income ÷ weighted average shares · filed 2018-03-14 | $1.54 derived: net income ÷ weighted average shares · filed 2018-03-14 | $2.25 derived: net income ÷ weighted average shares · filed 2018-03-14 | |
| 2015-12-31 | $0.48 10-K · filed 2016-03-04 | $0.93 derived: net income ÷ weighted average shares · filed 2018-03-14 | $1.65 derived: net income ÷ weighted average shares · filed 2018-03-14 | $1.77 10-K · filed 2016-03-04 | |
| 2015-09-30 | $0.47 10-Q · filed 2016-11-04 | $1.36 derived: net income ÷ weighted average shares · filed 2017-06-07 | $1.29 10-Q · filed 2016-11-04 | ||
| 2015-06-30 | $0.48 10-Q · filed 2016-08-05 | $0.82 10-Q · filed 2016-08-05 | |||
| 2015-03-31 | $0.34 10-Q · filed 2016-05-06 | ||||
| 2014-12-31 | $0.41 10-K · filed 2016-03-04 | $1.62 10-K · filed 2016-03-04 | |||
| 2014-09-30 | $0.43 10-K · filed 2016-03-04 | $1.21 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | $0.52 10-K · filed 2016-03-04 | $0.79 10-Q · filed 2015-08-06 | |||
| 2014-03-31 | $0.27 10-K · filed 2016-03-04 | ||||
| 2013-12-31 | $0.32 10-K · filed 2015-03-12 | $1.05 10-K · filed 2016-03-04 | |||
| 2013-09-30 | $0.02 10-K · filed 2015-03-12 | $0.74 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | $0.41 10-K · filed 2015-03-12 | $0.72 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | $0.31 10-K · filed 2015-03-12 | ||||
| 2012-12-31 | $0.33 10-K · filed 2014-03-11 | $0.34 10-K · filed 2013-03-12 | $1.52 10-K · filed 2015-03-12 | ||
| 2012-09-30 | $0.39 10-K · filed 2014-03-11 | $1.18 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $0.40 10-K · filed 2014-03-11 | $0.41 10-Q/A · filed 2012-09-06 | $0.79 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $0.37 10-K · filed 2014-03-11 | $0.38 10-Q · filed 2012-05-04 | |||
| 2011-12-31 | $0.70 10-K · filed 2013-03-12 | $1.78 10-K · filed 2014-03-11 | |||
| 2011-09-30 | $0.35 10-K · filed 2013-03-12 | $1.08 10-Q · filed 2012-11-09 | |||
| 2011-06-30 | $0.42 10-K · filed 2013-03-12 | $0.73 10-Q/A · filed 2012-09-06 | |||
| 2011-03-31 | $0.32 10-K · filed 2013-03-12 | ||||
| 2010-12-31 | $1.34 10-K · filed 2013-03-12 | ||||
| 2010-09-30 | $0.33 10-Q · filed 2011-11-08 | $0.99 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | $0.38 10-Q · filed 2011-08-04 | $0.66 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $1.01 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |